Press Releases
Press Releases
Allergan plc to add 322,000 square feet of manufacturing space in its Texas facility, costing $200 million
Expansion to add more than 100 full time jobs to local Waco and Central Texas economies -- Will add 322,000 square feet of manufacturing space, nearly doubling current footprint. Will increase Waco facility production capacity by...
Press Releases
CSL Celebrates 100 Years of Operation
Australia’s largest and most successful biotechnology company, CSL, will officially celebrate 100 years of operation on 25th April 2016. World pharma today/Press releases /-Originally named the ‘Commonwealth Serum Laboratories’, CSL was established in 1916 by the...
Press Releases
AstraZeneca launches integrated genomics approach to transform drug discovery and development
AstraZeneca and its global biologics research and development arm, MedImmune, today announced an integrated genomics initiative to transform drug discovery and development across its entire research and development pipeline. The initiative includes new collaborations with Human...
Press Releases
CPhI Istanbul hosts government and industry to strengthen Turkey as MENA pharma hub
CPhI Istanbul 2016, organised by UBM EMEA, returns for the third consecutive year to Turkey, co-located with InnoPack, ICSE and P-MEC. The four-in-one event will take place at the Istanbul Congress Center (ICC). Turkey, from...
Press Releases
Novo Nordisk plans to invest more than 100 million euros in production plants in Chartres, France
Novo Nordisk announced that it plans to invest more than 100 million euros in production facilities at its site in Chartres, France. The expansions will help Novo Nordisk meet the increasing worldwide demand for its diabetes medicines. ...
Press Releases
Eisai presents Non-Clinical Research Findings in 107th Annual Meeting of American Association for Cancer Research
Enhanced Mechanism Of Angiogenesis Inhibition And Anti-Tumor Activity In Renal Cell Carcinoma Investigated World pharma today/Press releases /-Eisai Co Ltd. announced that it has presented the results of non-clinical research investigating the combination of Eisai's in-house...
Press Releases
Baxter Receives Marketing Authorization of Nutrition for Preterm Newborns in UK and Denmark
Baxter International Inc announced it has received Marketing Authorization from the Competent Authorities in the United Kingdom and Denmark for NUMETA G13E 300 mL, a parenteral (intravenous) nutrition (PN) product. These national approvals are the first of 20 European...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read














